ofloxacin has been researched along with Aortic Valve Insufficiency in 2 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Aortic Valve Insufficiency: Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Candel, FJ | 1 |
| López, R | 1 |
| Valdivia, A | 1 |
| Núñez, MJ | 1 |
| Roca-Arbonés, V | 1 |
| Picazo de la Garza, JJ | 1 |
| Aepinus, C | 1 |
| Adolph, E | 1 |
| von Eiff, C | 1 |
| Podbielski, A | 1 |
| Petzsch, M | 1 |
1 review available for ofloxacin and Aortic Valve Insufficiency
| Article | Year |
|---|---|
[Endocarditis due to Stenotrophomonas maltophilia].
Topics: Aortic Valve Insufficiency; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Thera | 2002 |
1 other study available for ofloxacin and Aortic Valve Insufficiency
| Article | Year |
|---|---|
Kytococcus schroeteri: a probably underdiagnosed pathogen involved in prosthetic valve endocarditis.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Aortic Valve Insufficiency; DNA, Bacterial; Drug | 2008 |